January 12, 2022
Via: The Wall Street JournalBiopharmaceutical firm Pardes Biosciences Inc. plans to spend a large chunk of the funds it raised through a public offering late last month on a pill it is developing to treat Covid-19, including on manufacturing and hiring more clinical staff. […]
July 9, 2024
June 25, 2024